Summary:
Beacon Clinical Research is conducting a research study to evaluate a Phase 3 investigational treatment in subjects with Fibromyalgia.
Qualified Participants Must:
• Be 18 years of age or older
•
Have widespread pain in at least 11 of 18 specific tender point sites for 3 months
•
Not have a disorder that would otherwise explain the pain
Qualified Participants May Receive:
Study related care and compensation for time and travel.